SCHEMBL12677487

SCHEMBL12677487

CCCC(CCCCNC(C)=O)NC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
MAPK1 P28482 1/20 0.52
HIF1A Q16665 1/20 0.52
PAOX Q6QHF9 3/20 0.52
SIRT6 Q8N6T7 1/20 0.47
SIRT1 Q96EB6 1/20 0.47
FOLH1 Q04609 1/20 0.45
PLA2G2C Q5R387 1/20 0.44
ADRA1A P35348 1/20 0.43
PLA2G2A P14555 1/20 0.42
DPP7 Q9UHL4 2/20 0.42
ZDHHC7 Q9NXF8 1/20 0.41
GNAI3 P08754 1/20 0.41
GNAO1 P09471 1/20 0.41
GNAI1 P63096 1/20 0.41
EPHX1 P07099 3/20 0.40
SIRT5 Q9NXA8 1/20 0.39
RRM1 P23921 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13567005 0.87 KDM4E (0.54) KDM4EMAPK1HIF1APAOXSIRT6
SCHEMBL13057117 0.84 KDM4E (0.54) KDM4EMAPK1HIF1APAOXSIRT6
SCHEMBL17193095 0.83 PLA2G2C (0.60) SIRT6SIRT1PLA2G2CPLA2G2AZDHHC7
SCHEMBL2666555 0.83 PLA2G2C (0.60) SIRT6SIRT1PLA2G2CPLA2G2AZDHHC7
SCHEMBL19412266 0.83 PLA2G2C (0.60) SIRT6SIRT1PLA2G2CPLA2G2AZDHHC7
SCHEMBL11506429 0.83 PLA2G2C (0.59) PLA2G2CPLA2G2ADPP7TAS1R3TAS1R1
SCHEMBL10033481 0.82 TAS1R3 (0.50) PLA2G2CADRA1APLA2G2ATAS1R3TAS1R1
SCHEMBL825197 0.79 PAOX (0.49) KDM4EMAPK1HIF1APAOXSIRT6
SCHEMBL6940595 0.79 PLA2G2C (0.64) SIRT6SIRT1PLA2G2CPLA2G2AZDHHC7
SCHEMBL11606057 0.79 PLA2G2C (0.64) SIRT6SIRT1PLA2G2CPLA2G2AZDHHC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273343-B2 Protein-polymer conjugates PHARMAESSENTIA CORP. (TW) 2012-09-25 US disclosed
US-20110098451-A1 PEPTIDE-POLYMER CONJUGATES PHARMAESSENTIA CORP. (TW) 2011-04-28 US disclosed
US-20100029907-A1 PEPTIDE-POLYMER CONJUGATES PHARMAESSENTIA CORP. (TW) 2010-02-04 US disclosed
US-20090017004-A1 POLYMERIC DRUG DELIVERY SYSTEMS CONTAINING AN AROMATIC ALLYLIC ACID ENZON PHARMACEUTICALS, INC. (US) 2009-01-15 US disclosed
US-20090016985-A1 POLYMERIC DRUG DELIVERY SYSTEM CONTAINING A MULTI-SUBSTITUTED AROMATIC MOIETY ENZON PHARMACEUTICALS, INC. (US) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029907-A1 PEPTIDE-POLYMER CONJUGATES IFNG, EPOR, IFNAR1 KDM4E 4482/4885MAPK1 3789/4885HIF1A 115/4885
US-20090017004-A1 POLYMERIC DRUG DELIVERY SYSTEMS CONTAINING AN AROMATIC ALLYLIC ACID AADAC, ACSS2, ANXA6 KDM4E 1742/4885MAPK1 4791/4885HIF1A 1993/4885
US-20110098451-A1 PEPTIDE-POLYMER CONJUGATES EPOR, NPPA, ENPEP KDM4E 3758/4885MAPK1 3355/4885HIF1A 41/4885
US-20090016985-A1 POLYMERIC DRUG DELIVERY SYSTEM CONTAINING A MULTI-SUBSTITUTED AROMATIC MOIETY ABCB1, PAICS, ABCG2 KDM4E 430/4885MAPK1 4800/4885HIF1A 2527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.